Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
12/2003
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003CA2284446C New cyclic cycloalkylene chain derivatives, their preparation process and pharmaceutical compounds containing them
12/02/2003CA2254061C Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
11/2003
11/27/2003WO2003097649A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
11/27/2003WO2003097626A1 Manufacture of ascorbic acid esters
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003097576A2 Diamino-functional chalcones
11/27/2003WO2003097575A2 Amino-functional chalcones
11/27/2003WO2003097574A2 Aminoalkoxy-functional chalcones
11/27/2003WO2003097573A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003097036A1 N-acylaminoacetonitrile derivatives and their use for controlling parasites
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003WO2003011846A3 Process for the preparation of 5-substituted isobenzofurans
11/27/2003WO2003006425A3 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003US20030220521 A conjugate compound comprising an antagonist of adrenergic neurotransmitter, and second residue is capable of being cleaved by a kidney enzyme; sodium channel modulators, hypotensive agents
11/27/2003US20030220511 Novel compounds useful, for example, in optical switching and manufacturing method thereof
11/27/2003US20030220499 Novel spiro compounds
11/27/2003US20030220397 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
11/27/2003US20030220393 Substituted phthalides, a process for their preparations and pharmaceutical compositions containing them
11/27/2003US20030220390 Carbocyclic oxy amines such as 2-benzylidene-6-dimethylamino methylcyclohexanone, used as analgesics
11/27/2003US20030220371 Administering to a mammal an aromatic or heteroaromatic ring substituted triazole derivative to treat the conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, and obesity
11/27/2003US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
11/27/2003US20030220357 Reacting an aniline derivative with an acylchloride to form an intermeidate, cyclizing the intermediate, replacing hydroxy group with a leaving group (chloride), racting the product with an amino-heterocyclic compound
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220347 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
11/27/2003US20030220323 Such as (2-(4-(2-(1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy)-1-phenyl-ethyl) -piperazin-1-yl)-ethoxy)-acetic acid; for prevention and/or treatment of conditions associated with pathogical levels of substance P
11/27/2003US20030220315 Such as 3',3"-dibromo-4',4"-dimethoxy-5',5"-bis-(methoxycarbonyl)-1,1 -diphenylethene; for treating viral diseases/retroviruses
11/27/2003US20030219880 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof
11/27/2003US20030219832 Administered or coadministered with retinoid drugs to prevent or ameliorate toxicity or side effects caused by retinoids or vitamin A or vitamin A precursors
11/27/2003CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003CA2485214A1 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
11/27/2003CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003CA2483286A1 N-acylaminoacetonitrile derivatives and their use for controlling parasites
11/26/2003EP1364933A1 Optical resolver and method of optically resolving alcohol with the same
11/26/2003EP1364648A1 Cryptotanshinone for preventing and alleviating alzheimer's disease
11/26/2003EP1364647A1 Hypoglycemic agent
11/26/2003EP1363880A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1363876A1 Glucocorticoid receptor modulators
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1204659B1 Serotonergic benzofurans
11/26/2003EP1202982B1 Method for preparing a gamma-unsaturated beta-lactone and use thereof as an aromatic and flavouring ingredient
11/26/2003EP0974572B1 Novel process for producing alcohols
11/26/2003EP0927177B1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors
11/26/2003EP0689436B1 Taxanes not having an oxo group at c-9 and pharmaceutical compositions containing same
11/26/2003CN1128782C Catalyst for decarbonylation reaction
11/25/2003US6653346 Amtiischemic and antiinflammatory agents
11/25/2003US6653345 A prostanoic acid derivative as c-c chemokine synthesis inhibitor and useful for the treatment of circulatory diseases, inflammation, allergic and renal diseases
11/25/2003US6653340 2-amidino-5 or 6-benzofuranyl or benzothiophenyl 2-furanyl, thiophenyl or benzyl carboxylates; serine protease inhibitors potent against Factor D of the alternate complement pathway
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653321 Stimulating kinase activity of insulin receptor; type II diabetes; hyperglycemia
11/25/2003US6653309 Binding ligands
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/25/2003US6652823 Treatment of vanadium compound with formic acid, water and phosphorus compound
11/20/2003WO2003095440A1 Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making
11/20/2003WO2003095439A1 Methods for manufacture of dihydro-furan-2-one derivatives
11/20/2003WO2003095438A1 Substituted phenylacetamides and their use as glucokinase activators
11/20/2003WO2003095421A1 Amino acid analogues
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003087062A3 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
11/20/2003WO2003057173A3 Broad spectrum inhibitors
11/20/2003WO2003050154A3 Catalytic carbonylation of three and four membered heterocycles
11/20/2003WO2003050062A3 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS
11/20/2003WO2003006447A3 Interaction inhibitors of tcf-4 with beta-catenin
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003WO2001085664A8 Compounds and methods for regulating bacterial growth and pathogenesis
11/20/2003US20030216570 Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
11/20/2003US20030216435 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2003US20030216404 Hydroxamic acid derivatives
11/20/2003US20030216403 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent as well as treats asthma
11/20/2003US20030216260 Preparation by intramolecular cyclization
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003CA2484860A1 Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making
11/20/2003CA2484342A1 Methods for manufacture of dihydro-furan-2-one derivatives
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362462A2 A method and system for a low-overhead mobility management protocol in the internet protocol layer
11/19/2003EP1362043A1 Lactone compounds as novel photoinitiators
11/19/2003EP1362042A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1220848B1 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0766559B1 Cannabinoid receptor antagonists
11/19/2003CN1457337A Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
11/19/2003CN1456556A Di (5-formylfurfuryl) ether derivatives, preparations thereof and their uses in medicines
11/19/2003CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
11/18/2003USRE38324 Process for the preparation of hydroxy substituted gamma butyrolactones
11/18/2003US6649776 Producing alpha-methylenelactones by heating lactones with formaldehyde in supercritical fluid in presence of catalyst and phase transfer agent
11/18/2003US6649774 Catalysts and processes for the conversion of succinates to citraconates or itaconates
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649656 Anticarcinogenic, antiallergen, antishock, and antiasthmatic agents
11/18/2003US6649652 Prodrugs for antimicrobial amidines
11/18/2003US6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
11/18/2003US6649627 N-Substituted with 1- (pyrid-2-yl)-piperidine-4-yl radical; gastrointestinal and psychological disorder treatment; antidiabetic tocolytic, and antidepressant agents; irritable bowel syndrome, glaucoma and dysmenorrhoea
11/18/2003US6649624 Useful as neuropeptide Y receptor antagonists and as agents for therapy of cardiovascular disorders, central nervous system disorders, metabolic diseases
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
1 ... 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 ... 472